Positron Emission Tomography News and Research

RSS

Food increases thermogenesis of brown fat

Brown fat consumes energy, which is the reason why it could be important for preventing obesity and diabetes.

29 Aug 2018

Study shows link between thinning of the retina and early sign of Parkinson's disease

The eyes may be a window to the brain for people with early Parkinson's disease. People with the disease gradually lose brain cells that produce dopamine, a substance that helps control movement.

16 Aug 2018

Male tobacco smokers have decreased number of cannabinoid CB1 receptors, study reveals

Chronic, frequent tobacco smokers have a decreased number of cannabinoid CB1 receptors, the "pot receptor", when compared with non-smokers, reports a study in Biological Psychiatry.

15 Aug 2018

Researchers use PET tracer to identify ER expression differences in metastatic breast cancer patients

In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor expression of the metastases.

7 Aug 2018

New nuclear medicine test could improve care of patients with type 1 diabetes

Researchers have discovered a new nuclear medicine test that could improve care of patients with type 1 diabetes. The new positron emission tomography imaging method could measure beta-cell mass, which would greatly enhance the ability to monitor and guide diabetes therapies.

3 Aug 2018

Study finds wide variations in follow-up imaging for women with non-metastatic breast cancer

Follow-up imaging for women with non-metastatic breast cancer varies widely across the country, according to a new study led by researchers at UC San Francisco.

13 Jul 2018

UW-Madison researchers develop new method to track Parkinson's damage in the heart

A new way to examine stress and inflammation in the heart will help Parkinson's researchers test new therapies and explore an unappreciated way the disease puts people at risk of falls and hospitalization.

13 Jul 2018

New biosensor could enable early non-invasive diagnosis of Alzheimer's disease through magnetic resonance imaging

UPM researchers are involved in the development of a new biosensor that can be useful to achieve an early non-invasive diagnosis of Alzheimer's disease using magnetic resonance imaging.

12 Jul 2018

Study finds disrupted stress response in people with schizophrenia

Stressful situations affect the brain and body differently in people with schizophrenia compared to people without the mental illness or individuals at high risk for developing psychosis, a new CAMH study shows.

11 Jul 2018

Researchers develop personalized 'Therapeutic Intervention Fingerprint'

Personalized medicine - delivering therapies specially tailored to a patient's unique physiology - has been a goal of researchers and doctors for a long time.

11 Jul 2018

New TSPO-targeted PET imaging more fully evaluates extent of rheumatoid arthritis

A new positron emission tomography imaging method more fully evaluates the extent of rheumatoid arthritis by targeting translocator protein expression in the synovium (joint lining tissue).

10 Jul 2018

Finnish researchers gain new insights on brain activity during general anesthesia

Finnish researchers have gained new information on brain activity during general anesthesia by recording changes in the electrical activity of the brain.

3 Jul 2018

Study shows benefits, safety of long-lasting radionuclide therapy for patients with advanced NETs

A first-in-human study presented at the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging demonstrates the benefits and safety of a new, long-lasting type of radionuclide therapy for patients with advanced, metastatic neuroendocrine tumors.

26 Jun 2018

Novel theranostic agent designed for precise tumor diagnosis and therapy

A novel, intelligent theranostic agent for precise tumor diagnosis and therapy has been developed that remains as small molecules while circulating in the bloodstream, can then self-assemble into larger nanostructures in the tumor, and be activated by the tumor microenvironment for therapy guided by photoacoustic imaging.

26 Jun 2018

New molecular imaging method could help effectively tackle brain conditions

A new molecular imaging method can monitor the success of gene therapy in all areas of the brain, potentially allowing physicians to more effectively tackle brain conditions such as Parkinson's disease, Alzheimer's disease and multiple sclerosis.

26 Jun 2018

AntiCancer's oral drug overcomes gemcitabine resistance in mouse models of human pancreatic cancer

Pancreatic cancer is lethal in about 95% of cases mostly due to failure of first-line therapy gemcitabine. AntiCancer Inc.'s oral methioninase (AC 00619), which is in late pre-clinical development as an anti-cancer as well as an anti-aging drug, has now been shown to overcome gemcitabine resistance in mouse models of human pancreatic cancer, including AntiCancer's patient-derived orthotopic xenograft mouse models.

25 Jun 2018

AAA doses first patients in two clinical studies with PSMA-R2 for prostate cancer

Advanced Accelerator Applications S.A., a Novartis company and leader in nuclear medicine theragnostics, today announced that the first patients have been dosed in two Phase I/II clinical studies of radiolabeled PSMA-R2, a urea-based ligand of Prostate-Specific Membrane Antigen, which is commonly expressed on prostate cancer cells.

22 Jun 2018

Oxygen consumption in human BAT increases after a meal, shows research

The importance of the human brown adipose tissue has become clearer during the past ten years. Using functional imaging, positron emission tomography, PET, it was possible to show that adult humans have functional BAT.

20 Jun 2018

AFA awards grant to Stony Brook Medicine to improve drug development for Alzheimer's disease

The Alzheimer's Foundation of America is awarding $206,184 over the next three years to Stony Brook Medicine to support an innovative Positron Emission Tomography imaging research project that will compare neurons from healthy controls and those with Alzheimer's disease in an effort to improve drug development.

7 Jun 2018

Specific impairments within six large-scale brain networks linked to drug addiction behaviors

Specific impairments within six large-scale brain networks during drug cue exposure, decision-making, inhibitory control, and social-emotional processing are associated with drug addiction behaviors, according to a systematic review of more than 100 published neuroimaging studies by experts at the Icahn School of Medicine at Mount Sinai and published Wednesday, June 6 in the journal Neuron.

7 Jun 2018

Positron Emission Tomography News and Research

Food increases thermogenesis of brown fat

Study shows link between thinning of the retina and early sign of Parkinson's disease

Male tobacco smokers have decreased number of cannabinoid CB1 receptors, study reveals

Researchers use PET tracer to identify ER expression differences in metastatic breast cancer patients

New nuclear medicine test could improve care of patients with type 1 diabetes

Study finds wide variations in follow-up imaging for women with non-metastatic breast cancer

UW-Madison researchers develop new method to track Parkinson's damage in the heart

New biosensor could enable early non-invasive diagnosis of Alzheimer's disease through magnetic resonance imaging

Study finds disrupted stress response in people with schizophrenia

Researchers develop personalized 'Therapeutic Intervention Fingerprint'

New TSPO-targeted PET imaging more fully evaluates extent of rheumatoid arthritis

Finnish researchers gain new insights on brain activity during general anesthesia

Study shows benefits, safety of long-lasting radionuclide therapy for patients with advanced NETs

Novel theranostic agent designed for precise tumor diagnosis and therapy

New molecular imaging method could help effectively tackle brain conditions

AntiCancer's oral drug overcomes gemcitabine resistance in mouse models of human pancreatic cancer

AAA doses first patients in two clinical studies with PSMA-R2 for prostate cancer

Oxygen consumption in human BAT increases after a meal, shows research

AFA awards grant to Stony Brook Medicine to improve drug development for Alzheimer's disease

Specific impairments within six large-scale brain networks linked to drug addiction behaviors

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News